Jane Street
CALC icon

Jane Street’s CalciMedica CALC Stock Holding History

Jane Street’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-446
Closed -$169K – 9957
2021
Q2 		$169K Buy
+446
New +$146K ﹤0.01% 8952

Other funds holding CALC

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
LGM
L1 Global Manager Melbourne $142M AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jane Street's CALC Position: Q2 2026 in Review

Jane Street sold out of CalciMedica (CALC) in Q2 2026, closing a stake of 35,703 shares — an estimated $96.4K sold.

Jane Street first reported a position in CALC in Q1 2021 and held it in 5 quarters. The position peaked at $127K in Q4 2025. 31 funds tracked by Wall St. Rank hold CALC as of Q2 2026.

  • Jane Street reported no remaining CalciMedica position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 35,703 CalciMedica shares in Q2 2026, an estimated $96.4K.
  • Jane Street first reported a position in CalciMedica in Q1 2021 and held it in 5 quarters.
  • Jane Street's CalciMedica position peaked at $127K in Q4 2025.
  • 31 funds tracked by Wall St. Rank held CalciMedica as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.